HDAC10 and neoplasm: Specifically, down‐regulation of HDAC10 in tumour cells and continued activity of FGF and VEGF signalling pathways in transformed SCLC highlighted tumour‐intrinsic changes as the primary drivers of resistance, rather than alterations of the TME.